CytomX Therapeutics
CTMX
#9714
Rank
NZ$65.2 M
Marketcap
$0.81
Share price
-16.11%
Change (1 day)
-76.18%
Change (1 year)

Earnings for CytomX Therapeutics (CTMX)

Earnings in 2024 (TTM): NZ$43.48 Million

According to CytomX Therapeutics 's latest financial reports the company's current earnings are NZ$0.13 Billion. , an increase over its 2023 earnings that were of -NZ$11.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CytomX Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 NZ$44.65 M-485.49%
2023 -NZ$11.59 Million-94.62%
2022 -NZ$0.22 Billion43.84%
2021 -NZ$0.15 Billion72.37%
2020 -NZ$86.85 Million-52.66%
2019 -NZ$0.19 Billion31.83%
2018 -NZ$0.14 Billion68.34%
2017 -NZ$82.66 Million-20.95%
2016 -NZ$0.11 Billion73.99%
2015 -NZ$60.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.26 Billion-671.69%๐Ÿ‡บ๐Ÿ‡ธ USA